LEVY RAPHI (Chief Financial Officer) sold 15.4% of their position (20K shares) of ALPHA TAU MEDICAL LTD. on the open market
Open‑market sale worth $220.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/26/2026ACC: 0001213900-26-072349
Officer· Chief Financial Officer
Since Mar 2026
-20K
Net shares
Net seller
$220.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
20K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
−4.22K
Price / share
$11.00
Trade value
$46.44K
% of position
3.2%
6/25/2026
130.18K→125.96K
Ordinary Shares
Direct
Shares
−15.78K
Price / share
$11.00
Trade value
$173.56K
% of position
12.5%
6/25/2026
125.96K→110.18K
Total
Net shares
−20K
Net value
-$220K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/25/2026 | S · Sale | −4.22K | $11.00 | $46.44K | 3.2% | 130.18K | 125.96K |
| Ordinary Shares Direct | 6/25/2026 | S · Sale | −15.78K | $11.00 | $173.56K | 12.5% | 125.96K | 110.18K |
| Total | −20K | -$220K | ||||||
Derivative Transactions0
No derivative transactions reported